Health ❯ Healthcare

Clinical Trials

Drug Development Phase 3 Trials Drug Efficacy Patient Outcomes Phase III Trials Randomized Controlled Trials Research Studies Cancer Research Efficacy Studies Drug Approval

FDA Approves Lynkuet, a Nonhormonal Pill for Menopausal Hot Flashes

The once-daily therapy joins an emerging nonhormonal class with FDA-recommended liver tests at baseline and three months.

Mass General Removes Pig Kidney From Tim Andrews After Record 271 Days

AI App Matches Human-Led Diabetes Prevention in Phase 3 Trial

Online Tai Chi Program Eases Knee Osteoarthritis Pain in JAMA Trial

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

TCT 2025: Stent‑Sparing Balloons Match DES at One Year as Lower‑Cost Alternatives Rival IVL

Innovent Says Mazdutide Tops Semaglutide in China Phase 3 Diabetes Trial

FDA Approves Lynkuet, a Nonhormonal Pill for Menopausal Hot Flashes

First Human Trial Finds Enteral Ventilation Procedure Tolerable in Healthy Volunteers

FDA Expands Revumenib Approval to NPM1-Mutant Relapsed/Refractory AML in Patients 1 and Older

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

Moderna Scraps CMV Vaccine Program After Phase 3 Failure

Small Pediatric Study Links Pazopanib to Improved Two-Year Survival in Metastatic Ewing Sarcoma

FDA Approves Gazyva for Adults With Active Lupus Nephritis

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

First Human-Model Test Shows Enzyme-Converted Kidney Can Function After Blood-Type Switch

Digital Patient Outreach Raises Lung CT Screening to 24.5% in JAMA Trial

Adjuvant Pembrolizumab Cuts Risk of Distant Metastases in Merkel Cell Carcinoma at ESMO 2025

ctDNA-Guided Atezolizumab Extends Survival After Bladder Cancer Surgery in Phase III Trial